15 September 2015 - Two Public Summary Documents for nintedanib esylate from the March 2015 Pharmaceutical Benefits Advisory Committee (PBAC) meeting are now available.
For more details, go to: http://www.pbs.gov.au/info/industry/listing/elements/pbac-meetings/psd/pbac-public-summary-documents-march-2015